Feature | May 22, 2006| Kim Phelan

Movies, Money and Magnets

Kim Phelan, Editor

Ah, money, money, money — the Frankenstein monster that destroys souls.”
It’s one of many oddball lines from the zany 1930s Carole Lombard and William Powell comedy, “My Man Godfrey,” but it rings true for physicians and other clinicians who know all too well how money has often got healthcare by the throat.
Sometimes that’s evident in policies such as the President’s proposed budget for 2007 that would significantly cut healthcare spending. A flat budget allowance of $28.6 billion to the National Institutes of Health actually translates into a cut, argued AHA president Robert Eckel, after factoring in the inflation equation. It’s feared that spending for medical research, as well as funding for programs and ultimately — if you follow the logical trickle — medical device spending could all be adversely affected by the plan.
Quite naturally, money is frequently at the root, too, of device and technology spending decisions within the hospital or free-standing cath practice. At the end of the day those decisions, just like a Federal budget cut or freeze, impact those on the receiving end of cardiovascular treatments and procedures — the vulnerable patient whose life is on the line.
I sensed that money was definitely involved in the adoption rate of a technology discussed in this issue.
One of the “keynote” features we present is medical device consultant Larry Sieb’s investigation into magnetic navigation and its effectiveness in certain PCI and ablation procedures. When I read that one physician had successfully accomplished in 30 minutes what others had failed and abandoned after more than two hours, I thought: This sounds like a remarkable and reliable alternative to the traditional angiographic technique.
But it begged the question: If accuracy and throughput for some PCI and ablation procedures can be enhanced through application of this technology versus traditional angiography, why are only 40 facilities worldwide utilizing it?
To this Larry offered a few comments.
“Historically,” he said, “EP labs have received the cast-off equipment from the PCI labs. Budgeting a new system for EP labs is a relatively recent phenomenon driven primarily by increased procedures, which have increased the clout of the EP docs. Until this year, there has not been a driving application. But with the approval of the new ablation, magnetic navigation can now address the bulk of EP procedures, diagnostic, lead placement and now ablations. Dr. Tomasonni (a source in Sieb’s article beginning on page 26) will approximately double the number of magnetic- guided procedures in his rooms with just ablations.
“PCI is a little tougher since, at best, magnetic guidance could increase the number of patients in these labs by about 25 percent. That seems significant until one considers that magnetic guidance just about doubles the cost of a cath lab.”
Sieb explained that EP physicians are especially keen on magnetic navigation because it eliminates their exposure to radiation and the need to wear lead during procedures. He said PCI doctors are less convinced of its advantages, though as the number of cardiologists declines compared to the “exploding” number of patients, adoption of magnetic navigation is likely to climb. Till then, Sieb believes the majority of magnetic systems will be installed in either EP or combo EP/PCI labs.
Thanks for reading!

Related Content

Stereotaxis Receives Regulatory Approval of e-Contact Module in Canada
Technology | Ablation Systems| December 08, 2017
December 7, 2017 — Stereotaxis Inc.
CardioFocus Announces European CE Mark Approval of HeartLight Excalibur Balloon
Technology | Ablation Systems| October 10, 2017
October 10, 2017 — CardioFocus Inc. recently announced the European CE Mark approval of the HeartLight Excalibur Ball
The Apama Radiofrequency (RF) Balloon Catheter System.
News | Ablation Systems| October 02, 2017
October 2, 2017 — Boston Scientific announced a definitive agreement to acquire Apama Medical Inc., a privately-held
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Medtronic Announces First Enrollments in STOP AF First Clinical Trial
News | Ablation Systems| July 24, 2017
Medtronic plc recently announced first enrollments in the STOP AF First clinical trial. The trial will evaluate the...
Biosense Webster multi-electrode RF ablation balloon

Biosense Webster's multi-electrode RF ablation balloon with irrigation. The system allows operators to change the energy levels of each electrode to avoid damaging sensitive underlying critical structures like the esophagus or phrenic nerve.

Feature | Ablation Systems| May 17, 2017 | Dave Fornell
May 17, 2017 – Clinical trial results from a first-in-human study evaluating the acute feasibility of an investigatio
Abbott Announces CE Mark for New Cardiac Ablation Catheter
News | Ablation Systems| May 10, 2017
Abbott announced CE Mark of the TactiCath Contact Force Ablation Catheter, Sensor Enabled, developed to make it easier...
Medtronic, expanded indication, Freezor Xtra Cryoablation Catheter, AVNRT, atrioventricular nodal re-entrant tachycardia
Technology | Ablation Systems| February 16, 2017
Medtronic plc announced the U.S. Food and Drug Administration (FDA) has approved its Freezor Xtra Cryoablation Catheter...
CardioFocus, HeartLight Excalibur Balloon, 22nd Annual AF Symposium, atrial fibrillation, initial clinical evaluation
News | Ablation Systems| January 25, 2017
CardioFocus Inc. recently announced the initial clinical evaluation of the HeartLight Excalibur Balloon, a next-...
catheter ablations, atrial fibrillation, stroke risk, Intermountain Medical Center Heart Institute study, AHA Scientific Sessions, American Heart Association
News | Ablation Systems| November 14, 2016
Atrial fibrillation patients with a prior history of stroke who undergo catheter ablation lower their long-term risk of...
Overlay Init